Short description
OncoSec is a biotechnology company focusing on designing and developing gene therapies, therapeutics, and medical approaches.
Description
OncoSec Medical is an advanced-stage biomedical company that focuses on the development of novel therapeutic oncology products. The company's core technology is an untapped delivery system, that applies short electric impulses to a tumor, causing transient pores to open in the cellular membrane, allowing therapeutic agents to more readily enter cancer cells. This process is known as OMS electroporation. Using OMS electroporation in tandem with chemotherapeutic or biologic agents can selectively and effectively treat cancerous tumors and cells embedded among predominantly healthy tissue.
Last funding
Nopepepe
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2008
Exited on
April 7, 2010
Went public on
April 7, 2010
Stock symbol
ONCS
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$7890 - 12340
Sign in for full access
Investors
No Way, Noaccess
Sign in for full access
Founders
Punit Dhillon